Access Program Information
An expanded access/compassionate use protocol that allows access to Mylotarg for
relapsed/refractory AML CD33 positive patients in the USA.
Contact: B1761026@iconplc.com
An expanded access/compassionate use protocol that allows access to Mylotarg for
relapsed/refractory AML CD33 positive patients in the USA.
Contact: B1761026@iconplc.com